|
1
|
Wu J, Wang YC, Luo WJ, Bo D, Ye DW and Zhu
YP: Primary tumor surgery improves survival in non-metastatic
primary urethral carcinoma patients: A large population-based
investigation. BMC Cancer. 21(857)2021.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Janisch F, Abufaraj M, Fajkovic H, Kimura
S, Iwata T, Nyirady P, Rink M and Shariat SF: Current disease
management of primary urethral carcinoma. Eur Urol Focus.
5:722–734. 2019.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Wenzel M, Nocera L, Colla Ruvolo C,
Würnschimmel C, Tian Z, Shariat SF, Saad F, Briganti A, Tilki D,
Mandel P, et al: Incidence rates and contemporary trends in primary
urethral cancer. Cancer Causes Control. 32:627–634. 2021.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Williams C, Lamar M and Delgado P:
Urethral carcinoma: A compilation of case studies and research
findings. Urol Case Rep. 31(101169)2020.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Moch H, Cubilla AL, Humphrey PA, Reuter VE
and Ulbright TM: The 2016 WHO classification of tumours of the
urinary system and male genital Organs-Part A: Renal, penile, and
testicular tumours. Eur Urol. 70:93–105. 2016.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Shah RB, Montgomery JS, Montie JE and
Kunju LP: Variant (divergent) histologic differentiation in
urothelial carcinoma is under-recognized in community practice:
Impact of mandatory central pathology review at a large referral
hospital. Urol Oncol. 31:1650–1655. 2013.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Minato A, Fujimoto N and Kubo T: Squamous
differentiation predicts poor response to cisplatin-based
chemotherapy and unfavorable prognosis in urothelial carcinoma of
the urinary bladder. Clin Genitourin Cancer. 15:e1063–e1067.
2017.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Gellert LL, Warrick J and Al-Ahmadie HA:
Urothelial carcinoma with squamous differentiation-the pathologists
perspective. Urol Oncol. 33:437–443. 2015.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Gakis G, Witjes JA, Compérat E, Cowan NC,
De Santis M, Lebret T, Ribal MJ and Sherif AM: European Association
of Urology. EAU guidelines on primary urethral carcinoma. Eur Urol.
64:823–830. 2013.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Stewart SB, Leder RA and Inman BA: Imaging
tumors of the penis and urethra. Urol Clin North Am. 37:353–367.
2010.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Galgano SJ, Sivils C, Selph JP, Sanyal R,
Lockhart ME and Zarzour JG: The male urethra: Imaging and surgical
approach for common pathologies. Curr Probl Diagn Radiol.
50:410–418. 2021.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Gakis G, Bruins HM, Cathomas R, Compérat
EM, Cowan NC, van der Heijden AG, Hernández V, Linares Espinós EE,
Lorch A, Neuzillet Y, et al: European association of urology
guidelines on primary urethral carcinoma-2020 update. Eur Urol
Oncol. 3:424–432. 2020.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Karnes RJ, Breau RH and Lightner DJ:
Surgery for urethral cancer. Urol Clin North Am. 37:445–457.
2010.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Zinman LN and Vanni AJ: Management of
proximal primary urethral cancer: Should multidisciplinary therapy
be the gold standard? Urol Clin North Am. 43:505–513.
2016.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Spiess PE, Agarwal N, Bangs R, Boorjian
SA, Buyyounouski MK, Clark PE, Downs TM, Efstathiou JA, Flaig TW,
Friedlander T, et al: Bladder cancer, version 5.2017, NCCN clinical
practice guidelines in oncology. J Natl Compr Canc Netw.
15:1240–1267. 2017.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Smith Y, Hadway P, Ahmed S, Perry MJ,
Corbishley CM and Watkin NA: Penile-preserving surgery for male
distal urethral carcinoma. BJU Int. 100:82–87. 2007.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Gakis G, Morgan TM, Daneshmand S, Keegan
KA, Todenhöfer T, Mischinger J, Schubert T, Zaid HB, Hrbacek J,
Ali-El-Dein B, et al: Impact of perioperative chemotherapy on
survival in patients with advanced primary urethral cancer: Results
of the international collaboration on primary urethral carcinoma.
Ann Oncol. 26:1754–1759. 2015.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Kim HS and Seo HK: Immune checkpoint
inhibitors for urothelial carcinoma. Investig Clin Urol.
59:285–296. 2018.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Miyama Y, Morikawa T, Miyakawa J, Koyama
Y, Kawai T, Kume H and Ushiku T: Squamous differentiation is a
potential biomarker predicting tumor progression in patients
treated with pembrolizumab for urothelial carcinoma. Pathol Res
Pract. 219(153364)2021.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Gulmann C, Paner GP, Parakh RS, Hansel DE,
Shen SS, Ro JY, Annaiah C, Lopez-Beltran A, Rao P, Arora K, et al:
Immunohistochemical profile to distinguish urothelial from squamous
differentiation in carcinomas of urothelial tract. Hum Pathol.
44:164–172. 2013.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Liu Y, Bui MM and Xu B: Urothelial
carcinoma with squamous differentiation is associated with high
tumor stage and pelvic lymph-node metastasis. Cancer Control.
24:78–82. 2017.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Minato A, Noguchi H, Tomisaki I, Fukuda A,
Kubo T, Nakayama T and Fujimoto N: Clinical significance of
squamous differentiation in urothelial carcinoma of the bladder.
Cancer Control. 25(1073274818800269)2018.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Zhang M, Adeniran AJ, Vikram R, Tamboli P,
Pettaway C, Bondaruk J, Liu J, Baggerly K and Czerniak B: Carcinoma
of the urethra. Hum Pathol. 72:35–44. 2018.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Gaisa NT, Braunschweig T, Reimer N,
Bornemann J, Eltze E, Siegert S, Toma M, Villa L, Hartmann A and
Knuechel R: Different immunohistochemical and ultrastructural
phenotypes of squamous differentiation in bladder cancer. Virchows
Arch. 458:301–312. 2011.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Ko LJ, Yamamoto M, Leonard MW, George KM,
Ting P and Engel JD: Murine and human T-lymphocyte GATA-3 factors
mediate transcription through a cis-regulatory element within the
human T-cell receptor delta gene enhancer. Mol Cell Biol.
11:2778–2784. 1991.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Chaux A, Han JS, Lee S, Gonzalez-Roibon N,
Sharma R, Burnett AL, Cubilla AL and Netto GJ: Immunohistochemical
profile of the penile urethra and differential expression of GATA3
in urothelial versus squamous cell carcinomas of the penile
urethra. Hum Pathol. 44:2760–2767. 2013.PubMed/NCBI View Article : Google Scholar
|
